BrainScope Develops Device For TBI/Concussion Assessment
This article was originally published in The Gray Sheet
Executive SummaryNeurology firm BrainScope aims to begin a clinical trial in U.S. emergency departments within the next several months for its Ahead M-100 to aid in the detection and assessment of traumatic brain injury.
You may also be interested in...
Banyan Biomarkers blood-based assay works by detecting the presence of two proteins that only cross the blood-brain barrier if there’s been a brain injury. An IDE was filed July 2 and the firm hopes for PMA approval in 2014.